• Corpus ID: 42866587

Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.

@article{Verani2010PreventionOP,
  title={Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.},
  author={Jennifer R Verani and Lesley McGee and Stephanie Schrag},
  journal={MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports},
  year={2010},
  volume={59 RR-10},
  pages={
          1-36
        }
}
  • J. Verani, L. McGee, S. Schrag
  • Published 2010
  • Medicine
  • MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the United States. In 1996, CDC, in collaboration with relevant professional societies, published guidelines for the prevention of perinatal group B streptococcal disease (CDC. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45[No. RR-7]); those guidelines were updated and… 

Figures and Tables from this paper

Prevention of perinatal group B streptococcal disease: updated CDC guideline.
TLDR
The algorithm for secondary prevention of early-onset group B streptococcal disease in newborns should be applied to all infants, not only those at high risk of infection, and the extent of evaluation and duration of observation required for infants in different risk categories is clarified.
Prevention and Management of Infants With Suspected or Proven Neonatal Sepsis
TLDR
The 2012 COFN document includes guidance on laboratory evaluations and treatment duration, which were not addressed in the 2010 GBS prevention guidelines, which prompted questions by the pediatric community as to which recommendations to follow.
Updated Guidance: Prevention and Management of Perinatal Group B Streptococcus Infection.
TLDR
Maternal intrapartum antibiotic prophylaxis based on antenatal screening for GBS colonization remains the primary recommended approach to prevent perinatal GBS disease, though the optimal window for screening is changed to 36 0/7 to 37 6/7 weeks of gestation rather than beginning at 35 0/ 7 weeks' gestation.
[Prevention of neonatal group B streptococcal sepsis in Hungary in 2012. Preliminary data of a nation-wide survey].
TLDR
Lack of a nation-wide public health policy did not prevent obstetric institutions in this country to develop their own prevention strategy, and in the majority of cases and institutions, the policy is consistent with the widely accepted international standards.
Prevention of neonatal group B streptococcus disease in the 21st century
TLDR
An update of GBS preventative management strategies in the perinatal period taking into account recent United States, Australian and New Zealand guidelines is provided.
Strategies for preventing group B streptococcal infections in newborns: a nation-wide survey of Italian policies
TLDR
The screening-based strategy is largely prevalent in Italy, and most protocols for preventing GBS early-onset sepsis are consistent with CDC guidelines, however, there are discrepancies in practices among centers that may reflect the lack of Italian guidelines issued by public health organizations.
ACOG Committee Opinion No. 279: Prevention of Early‐Onset Group B Streptococcal Disease in Newborns
  • P. Benn
  • Medicine
    Obstetrics and gynecology
  • 2011
TLDR
The Committee on Obstetric Practice endorses the new Centers for Disease Control and Prevention recommendations, and recognizes that even complete implementation of this complex strategy will not eliminate all cases of early-onset group B streptococcal disease.
Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project
TLDR
The DEVANI pan-European program, launched in 2008, was to assess the GBS neonatal infection burden in Europe, to design a new vaccine to immunize neonates against GBS infections, and to improve the laboratory performance for the diagnosis of GBS colonization and infection.
Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797.
  • Medicine
    Obstetrics and gynecology
  • 2020
TLDR
The key obstetric measures necessary for effective prevention of GBS EOD continue to include universal prenatal screening by vaginal-rectal culture, correct specimen collection and processing, appropriate implementation of intrapartum antibiotic prophylaxis, and coordination with pediatric care providers.
...
...

References

SHOWING 1-10 OF 279 REFERENCES
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.
TLDR
Although universal screening for GBS colonization is anticipated to result in further reductions in the burden of GBS disease, the need to monitor for potential adverse consequences of intrapartum antibiotic use, such as emergence of bacterial antimicrobial resistance or increased incidence or severity of non-GBS neonatal pathogens, continues.
Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005.
TLDR
Investigation of surveillance data from the Active Bacterial Core surveillance (ABCs) system indicated that annual incidence of early onset GBS disease was 33% lower during 2003-2005 than during 2000-2001, and incidence among white infants and pregnant women remained stable after revised universal screening guidelines were issued.
Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization.
TLDR
The new consensus guidelines issued to prevent perinatal group B streptococcal disease were associated with increased maternal intrapartum antibiotic use, particularly among women at highest risk, and with a decrease in laboratory use for infants.
Trends in perinatal group B streptococcal disease - United States, 2000-2006.
TLDR
An increase in the overall rate of early-onset GBS disease from 2003 to 2006 was revealed, driven by an increasing incidence among black term infants.
Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.
TLDR
The selection of pregnant women for chemoprophylaxis and an algorithm for management of their newborns are reviewed and supported by the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics.
Neonatal Group B Streptococcal Disease: How Infection Control Teams Can Contribute to Prevention Efforts
TLDR
By spearheading efforts to improve implementation of perinatal GBS disease prevention at the hospital level, hospital epidemiologists and infection control practitioners can play an important role in reducing the burden of early-onset GBS Disease.
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.
TLDR
Over a six-year period, there has been a substantial decline in the incidence of group B streptococcal disease in newborns, including a major reduction in the excess incidence of these infections in black infants.
Prevention of neonatal group B streptococcal disease: A combined intrapartum and neonatal protocol.
TLDR
Combined maternal and infant antimicrobial prophylaxis can significantly and safely reduce rates of early-onset GBS infection in both preterm and term infants.
Perinatal infections due to group B streptococci.
TLDR
The epidemiology, diagnosis, and therapy of GBS perinatal infection is reviewed, including implementation of new diagnostic techniques, management of preterm rupture of membranes, use of alternative antibiotic approaches, improvement of compliance, prevention of low birth weight infants, emergence of resistant organisms, and vaccine development.
A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates.
TLDR
Routine screening for group B streptococcus during pregnancy prevents more cases of early-onset disease than the risk-based approach, and recommendations that endorse both strategies as equivalent warrant reconsideration.
...
...